jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Pharmacology and PharmacotherapeuticsNOW IN
Article

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis

Sushil Sharma1★, A G Mathur1, Sapna Pradhan1, D B Singh1, Sparsh Gupta1★ Corresponding author

  1. 1Department of Pharmacology, Army College of Medical Sciences, Delhi Cantt, New Delhi, India Molecules of the Millennium.

CORRESPONDENCE

Sushil Sharma

Department of Pharmacology, Army College of Medical Sciences, Delhi Cantt, New Delhi, India Molecules of the Millennium.

sushkehar@rediffmail.com

Volume 2, Issue 1 · pp. 49–51 · PUBLISHED 2011 · DOI: 10.4103/0976-500X.77118

View on JPP original site ↗

ABSTRACT

KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Sharma, S., Mathur, A. G., Pradhan, S., Singh, D. B., & Gupta, S. (2011). Fingolimod (FTY720): First approved oral therapy for multiple sclerosis. Journal of Pharmacology and Pharmacotherapeutics, 2(1), 49–51. https://doi.org/10.4103/0976-500X.77118